These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26266098)

  • 41. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
    Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
    Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.
    Bhattacharya IS; Woolf DK; Hughes RJ; Shah N; Harrison M; Ostler PJ; Hoskin PJ
    Br J Radiol; 2015 Apr; 88(1048):20140712. PubMed ID: 25679321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
    Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
    Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
    Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
    Siva S; MacManus M; Ball D
    J Thorac Oncol; 2010 Jul; 5(7):1091-9. PubMed ID: 20479693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Trovo M; Furlan C; Polesel J; Fiorica F; Arcangeli S; Giaj-Levra N; Alongi F; Del Conte A; Militello L; Muraro E; Martorelli D; Spazzapan S; Berretta M
    Radiother Oncol; 2018 Jan; 126(1):177-180. PubMed ID: 28943046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Review of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Prostate Cancer.
    Zhang B; Leech M
    Anticancer Res; 2020 May; 40(5):2419-2428. PubMed ID: 32366385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review.
    Aoki S; Yamashita H; Abe O; Nakagawa K
    Transl Cancer Res; 2020 Aug; 9(8):5087-5095. PubMed ID: 35117874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic body radiation therapy for metastases to the kidney in patients with non-small cell lung cancer: a new treatment paradigm for durable palliation.
    Verma V; Simone CB
    Ann Palliat Med; 2017 Apr; 6(2):96-103. PubMed ID: 28480719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic body radiotherapy for oligometastatic disease.
    Hanna GG; Landau D
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
    Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
    World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.
    Lazzari R; Ronchi S; Gandini S; Surgo A; Volpe S; Piperno G; Comi S; Pansini F; Fodor C; Orecchia R; Tomao F; Parma G; Colombo N; Jereczek-Fossa BA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):650-660. PubMed ID: 29893277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
    Schroeder SR; Leenders M; Iyengar P; de Ruysscher D
    Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S184-S191. PubMed ID: 31673523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
    Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
    Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Billing DL; Rimner A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases.
    Kumar R; Nater A; Hashmi A; Myrehaug S; Lee Y; Ma L; Redmond K; Lo SS; Chang EL; Yee A; Fisher CG; Fehlings MG; Sahgal A
    Neurooncol Pract; 2016 Mar; 3(1):48-58. PubMed ID: 31579521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.